JESSICA VELARDI: Open Payments
NPI 1215325147 · ORANGE, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,560 in 143 payments from 21 companies in 2025. Trend: 2023 $2,679 · 2024 $4,834 · 2025 $3,560
Food & beverage: $3,475Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $550 |
| Incyte Corporation | 21 | $504 |
| PFIZER INC. | 18 | $497 |
| ABBVIE INC. | 25 | $375 |
| UCB, Inc. | 5 | $198 |
| LEO Pharma Inc. | 8 | $181 |
| Regeneron Healthcare Solutions, Inc. | 8 | $176 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $170 |
| Lilly USA, LLC | 6 | $149 |
| REVANCE THERAPEUTICS, INC. | 1 | $149 |
Products named: TREMFYA, Opzelura, CIBINQO, DUPIXENT, SKYRIZI, Bimzelx, ADBRY, DAXXIFY.
Industry payments across CT — which companies pay providers there.
